Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
This study has been completed.
Study NCT00442611   Information provided by Stanford University

First Received on March 1, 2007.   Last Updated on July 20, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Scleroderma, Diffuse
Scleroderma, Systemic
Additional conditions recognized in this trial
Scleroderma, Localized
Sclerosis
More general conditions related to this trial
Connective Tissue Diseases
Pathologic Processes
Skin Diseases
Interventions listed in this trial
Abatacept
More general drug interventions related to this trial
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Stanford University
Bristol-Myers Squibb


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services